Pacira BioSciences is a corporate strategic investor and biopharmaceutical company based in Parsippany, New Jersey, focused on non-opioid and opioid-sparing pain-management opportunities. It targets on-market and development-stage assets, including later-stage opportunities with clinical data, across biotechnology, HealthTech, life sciences and pharmaceuticals. The company invests in the United States and has acted as a lead investor, making it relevant for healthcare and biotech founders with pain-management, neurology or adjacent therapeutic assets.